.png)
.png)
.jpg "Anne F. Luetkemeyer, MD photo")
Professor of Medicine
Zuckerberg San Francisco General, University of California, San Francisco, CA, USA
Disclosure(s): AstraZeneca: Grant/Research Support; Gilead Sciences: Grant/Research Support
Annie Luetkemeyer, MD is a professor of medicine in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital at University of California, San Francisco. Dr. Luetkemeyer is the principal investigator for the UCSF AIDS Clinical Trials Group (ACTG) clinical research site and directs the San Francisco General HHRC, which conducts infectious diseases clinical trials. She is the co-PI for the NIH funded DoxyPEP study, investigating the use of post-exposure doxycycline to reduce bacterial sexually transmitted infections in MSM and TGW.